Maberry, Shelley – Trademark Portfolio

Entity Type: 01

Maberry, Shelley holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DREAMER, BELIEVER, ACHIEVER THE NEW DBA. The owner is based in BELLEVILLE, IL.

4226 WOODFIELD PLACE

BELLEVILLE, IL 62226

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Maberry, Shelley's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Maberry, Shelley have?

Maberry, Shelley has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Maberry, Shelley file in?

Maberry, Shelley files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.

What are Maberry, Shelley's most well-known trademarks?

Maberry, Shelley's registered trademark portfolio includes well-known marks such as DREAMER, BELIEVER, ACHIEVER THE NEW DBA. These are among 1 currently registered trademark in the portfolio.

What is Maberry, Shelley's trademark registration success rate?

Maberry, Shelley has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.